Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
Subscribe To Our Newsletter & Stay Updated
